Pfizer: Alzheimer Disease trials

The registry lists 101 Alzheimer Disease studies with Pfizer as lead sponsor. 1 are open to participants now and 40 have results posted.

Phase 1 52Phase 2 27Phase 3 17No phase 8(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's PatientsCompletedNCT00141661Phase 2